National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 588577

History of Changes from the VAERS Wayback Machine

First Appeared on 10/14/2017

VAERS ID: 588577
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2015-07-28
Entered:2015-07-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1507GBR011813

Write-up: Information has been received from Sanofi Pasteur MSD (Sender case report number GB-1577272925-E2015-08469) on 24-JUL-2015. Serious case received from a consumer via lay press on 19/Jul/2015. This case is not medically confirmed. This case is linked to E2015-08375 (same reporter). An unknown number of female patients of unreported age, with no concomitant medication reported, received injections of GARDASIL, (batch number not reported), series site and route not reported, on unreported date. The majority of the teenagers were perfectly healthy prior to vaccination. On unreported dates, some young people have died following vaccination with most post mortem results unable to show a conclusive cause of death. A petition, from the Agency of HPV Vaccine Injured Patients, stated that there was a growing pattern of illness emerging among young girls since the vaccine was introduced. The agency has been contacted by more than 130 families since 2008 and more than half of these have come forward indicating the rate was accelerating. The case was considered serious for death.


Changed on 2/14/2018

VAERS ID: 588577 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2015-07-28
Entered:2015-07-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1507GBR011813

Write-up: Information has been received from Sanofi Pasteur MSD (Sender case report number GB-1577272925-E2015-08469) on 24-JUL-2015. Serious case received from a consumer via lay press on 19/Jul/2015. This case is not medically confirmed. This case is linked to E2015-08375 (same reporter). An unknown number of female patients of unreported age, with no concomitant medication reported, received injections of GARDASIL, (batch number not reported), series site and route not reported, on unreported date. The majority of the teenagers were perfectly healthy prior to vaccination. On unreported dates, some young people have died following vaccination with most post mortem results unable to show a conclusive cause of death. A petition, from the Agency of HPV Vaccine Injured Patients, stated that there was a growing pattern of illness emerging among young girls since the vaccine was introduced. The agency has been contacted by more than 130 families since 2008 and more than half of these have come forward indicating the rate was accelerating. The case was considered serious for death.


Changed on 6/14/2018

VAERS ID: 588577 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2015-07-28
Entered:2015-07-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1507GBR011813

Write-up: Information has been received from Sanofi Pasteur MSD (Sender case report number GB-1577272925-E2015-08469) on 24-JUL-2015. Serious case received from a consumer via lay press on 19/Jul/2015. This case is not medically confirmed. This case is linked to E2015-08375 (same reporter). An unknown number of female patients of unreported age, with no concomitant medication reported, received injections of GARDASIL, (batch number not reported), series site and route not reported, on unreported date. The majority of the teenagers were perfectly healthy prior to vaccination. On unreported dates, some young people have died following vaccination with most post mortem results unable to show a conclusive cause of death. A petition, from the Agency of HPV Vaccine Injured Patients, stated that there was a growing pattern of illness emerging among young girls since the vaccine was introduced. The agency has been contacted by more than 130 families since 2008 and more than half of these have come forward indicating the rate was accelerating. The case was considered serious for death.


Changed on 8/14/2018

VAERS ID: 588577 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2015-07-28
Entered:2015-07-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1507GBR011813

Write-up: Information has been received from Sanofi Pasteur MSD (Sender case report number GB-1577272925-E2015-08469) on 24-JUL-2015. Serious case received from a consumer via lay press on 19/Jul/2015. This case is not medically confirmed. This case is linked to E2015-08375 (same reporter). An unknown number of female patients of unreported age, with no concomitant medication reported, received injections of GARDASIL, (batch number not reported), series site and route not reported, on unreported date. The majority of the teenagers were perfectly healthy prior to vaccination. On unreported dates, some young people have died following vaccination with most post mortem results unable to show a conclusive cause of death. A petition, from the Agency of HPV Vaccine Injured Patients, stated that there was a growing pattern of illness emerging among young girls since the vaccine was introduced. The agency has been contacted by more than 130 families since 2008 and more than half of these have come forward indicating the rate was accelerating. The case was considered serious for death.


Changed on 9/14/2018

VAERS ID: 588577 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2015-07-28
Entered:2015-07-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1507GBR011813

Write-up: Information has been received from Sanofi Pasteur MSD (Sender case report number GB-1577272925-E2015-08469) on 24-JUL-2015. Serious case received from a consumer via lay press on 19/Jul/2015. This case is not medically confirmed. This case is linked to E2015-08375 (same reporter). An unknown number of female patients of unreported age, with no concomitant medication reported, received injections of GARDASIL, (batch number not reported), series site and route not reported, on unreported date. The majority of the teenagers were perfectly healthy prior to vaccination. On unreported dates, some young people have died following vaccination with most post mortem results unable to show a conclusive cause of death. A petition, from the Agency of HPV Vaccine Injured Patients, stated that there was a growing pattern of illness emerging among young girls since the vaccine was introduced. The agency has been contacted by more than 130 families since 2008 and more than half of these have come forward indicating the rate was accelerating. The case was considered serious for death.


Changed on 10/14/2018

VAERS ID: 588577 Before After
VAERS Form:1
Age:
Sex:Female
Location:Foreign
Vaccinated:0000-00-00
Onset:0000-00-00
Submitted:2015-07-28
Entered:2015-07-28
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV4: HPV (GARDASIL) / MERCK & CO. INC. - / UNK UN / UN

Administered by: Other      Purchased by: Other
Symptoms: Death

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died:0000-00-00
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: No other medications
Current Illness: Immunisation
Preexisting Conditions:
Allergies:
Diagnostic Lab Data:
CDC 'Split Type': WAES1507GBR011813

Write-up: Information has been received from Sanofi Pasteur MSD (Sender case report number GB-1577272925-E2015-08469) on 24-JUL-2015. Serious case received from a consumer via lay press on 19/Jul/2015. This case is not medically confirmed. This case is linked to E2015-08375 (same reporter). An unknown number of female patients of unreported age, with no concomitant medication reported, received injections of GARDASIL, (batch number not reported), series site and route not reported, on unreported date. The majority of the teenagers were perfectly healthy prior to vaccination. On unreported dates, some young people have died following vaccination with most post mortem results unable to show a conclusive cause of death. A petition, from the Agency of HPV Vaccine Injured Patients, stated that there was a growing pattern of illness emerging among young girls since the vaccine was introduced. The agency has been contacted by more than 130 families since 2008 and more than half of these have come forward indicating the rate was accelerating. The case was considered serious for death.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=588577&WAYBACKHISTORY=ON


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166